INVESTABOT
Equity Research
XNYS · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Includes notes from domestic 8-K and foreign private issuer 6-K disclosures.
ResMed (RMD) had 1 Form 144 pre-sale notice filed on 2026-07-07. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing refere…
ResMed (RMD) had 1 Form 144 pre-sale notice filed on 2026-06-08. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing refere…
ResMed (RMD) had 1 Form 144 pre-sale notice filed on 2026-05-27. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction.
TL;DR: ResMed posted Q3 fiscal 2026 revenue of $1.43B, up 10.8% from $1.29B in the year-ago quarter, with GAAP gross margin expanding 290 basis points to 62.2%.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 8/7/2026 | Farrell Michael J. | Chairman and CEO | OPTION_EXERCISE | -4,991 | — | — |
| 8/7/2026 | Farrell Michael J. | Chairman and CEO | SELL | -4,991 | $206 | $1,026,596 |
| 8/7/2026 | Farrell Michael J. | Chairman and CEO | OPTION_EXERCISE | 4,991 | $146 | $730,383 |
| 8/5/2026 | FARRELL PETER C | — | SELL | -8,000 | $225 | $1,800,000 |
| 7/7/2026 | Farrell Michael J. | Chairman and CEO | OPTION_EXERCISE | -4,991 | — | — |
| 7/7/2026 | Farrell Michael J. | Chairman and CEO | SELL | -4,991 | $219 | $1,090,771 |
| 7/7/2026 | Farrell Michael J. | Chairman and CEO | OPTION_EXERCISE | 4,991 | $146 | $730,383 |
| 6/8/2026 | Farrell Michael J. | Chairman and CEO | OPTION_EXERCISE | -4,991 | — | — |
| 6/8/2026 | Farrell Michael J. | Chairman and CEO | SELL | -4,991 | $194 | $968,064 |
| 6/8/2026 | Farrell Michael J. | Chairman and CEO | OPTION_EXERCISE | 4,991 | $146 | $730,383 |
| 6/1/2026 | Rider Michael J | Global General Counsel | TAX_WITHHOLD | -268.74 | $191 | $51,214 |
| 5/7/2026 | Farrell Michael J. | Chairman and CEO | OPTION_EXERCISE | -4,991 | — | — |
| 5/7/2026 | Farrell Michael J. | Chairman and CEO | SELL | -4,991 | $208 | $1,037,233 |
| 5/7/2026 | Farrell Michael J. | Chairman and CEO | OPTION_EXERCISE | 4,991 | $146 | $730,383 |
| 4/7/2026 | Farrell Michael J. | Chairman and CEO | OPTION_EXERCISE | 4,991 | $146 | $730,383 |
| 4/7/2026 | Farrell Michael J. | Chairman and CEO | SELL | -4,991 | $226 | $1,125,486 |
| 4/7/2026 | Farrell Michael J. | Chairman and CEO | OPTION_EXERCISE | -4,991 | — | — |
| 4/1/2026 | Sandercock Brett | Chief Financial Officer | SELL | -1,000 | $224 | $224,310 |
| 4/1/2026 | FARRELL PETER C | — | SELL | -2,000 | $225 | $450,000 |
| 3/9/2026 | Farrell Michael J. | Chairman and CEO | OPTION_EXERCISE | 4,991 | $146 | $730,383 |
| Date | Insider | Title | Relationship | Shares | Filing |
|---|---|---|---|---|---|
| 5/4/2026 | — | — | — | — | SEC |
| Institution | Shares | Value ($) | Change % | Filing date |
|---|---|---|---|---|
| Vanguard Group | 18,882,403 | $4,548,204,411 | — | 1/29/2026 |
| BlackRock | 12,348,652 | $2,974,419,664 | — | 2/12/2026 |
| BlackRock | 12,094,023 | $2,714,866,496 | -2.1% | 5/13/2026 |
| BlackRock | 12,317,194 | $2,400,374,750 | 1.9% | 8/7/2026 |
| BlackRock | 11,691,961 | $2,238,075,134 | — | 8/13/2024 |
| State Street | 6,625,408 | $1,595,862,025 | — | 2/13/2026 |
| State Street | 6,643,168 | $1,491,258,353 | 0.3% | 5/15/2026 |
| State Street | 6,680,735 | $1,301,941,637 | 0.6% | 8/7/2026 |
| Morgan Stanley | 2,891,697 | $696,523,345 | — | 5/27/2026 |
| Morgan Stanley | 2,686,821 | $603,138,265 | -7.1% | 5/15/2026 |
| Morgan Stanley | 1,928,931 | $375,910,899 | -28.2% | 8/13/2026 |
| Goldman Sachs | 979,419 | $235,912,822 | — | 3/25/2026 |
| Goldman Sachs | 1,160,426 | $226,143,898 | 15.6% | 8/14/2026 |
| Goldman Sachs | 1,004,205 | $225,424,028 | 2.5% | 5/15/2026 |
| AQR Capital | 910,623 | $177,143,337 | 160.3% | 8/14/2026 |
| JP Morgan Chase | 847,736 | $168,216,509 | 17.9% | 8/12/2026 |
| JP Morgan Chase | 719,347 | $158,278,078 | 18.8% | 5/13/2026 |
| JP Morgan Chase | 605,408 | $145,824,771 | — | 2/11/2026 |
| Citadel Advisors | 610,484 | $118,971,122 | 45.3% | 8/14/2026 |
| Fidelity (FMR) | 415,813 | $100,156,849 | — | 2/17/2026 |